 Adenocarcinoma
"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant epithelial tumor with a glandular organization.
| Descriptor ID |
D000230
|
| MeSH Number(s) |
C04.557.470.200.025
|
| Concept/Terms |
Adenocarcinoma- Adenocarcinoma
- Adenocarcinomas
- Adenoma, Malignant
- Adenomas, Malignant
- Malignant Adenoma
- Malignant Adenomas
Carcinoma, Granular Cell- Carcinoma, Granular Cell
- Carcinomas, Granular Cell
- Granular Cell Carcinoma
- Granular Cell Carcinomas
- Adenocarcinoma, Granular Cell
- Adenocarcinomas, Granular Cell
- Granular Cell Adenocarcinoma
- Granular Cell Adenocarcinomas
Adenocarcinoma, Tubular- Adenocarcinoma, Tubular
- Adenocarcinomas, Tubular
- Tubular Adenocarcinoma
- Tubular Adenocarcinomas
- Carcinoma, Tubular
- Carcinomas, Tubular
- Tubular Carcinoma
- Tubular Carcinomas
Carcinoma, Cribriform- Carcinoma, Cribriform
- Carcinomas, Cribriform
- Cribriform Carcinoma
- Cribriform Carcinomas
Adenocarcinoma, Basal Cell- Adenocarcinoma, Basal Cell
- Adenocarcinomas, Basal Cell
- Basal Cell Adenocarcinoma
- Basal Cell Adenocarcinomas
Adenocarcinoma, Oxyphilic- Adenocarcinoma, Oxyphilic
- Adenocarcinomas, Oxyphilic
- Oxyphilic Adenocarcinoma
- Oxyphilic Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma".
- Adenocarcinoma
- Adenocarcinoma in Situ
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenocarcinoma, Mucinous
- Adenocarcinoma, Papillary
- Adenocarcinoma, Scirrhous
- Adenocarcinoma, Sebaceous
- Adrenocortical Carcinoma
- Carcinoid Tumor
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Skin Appendage
- Cholangiocarcinoma
- Choriocarcinoma
- Cystadenocarcinoma
- Eccrine Porocarcinoma
- Paget Disease, Extramammary
- Pulmonary Adenomatosis, Ovine
This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 5 | 8 | | 1997 | 2 | 1 | 3 | | 1998 | 3 | 0 | 3 | | 1999 | 7 | 3 | 10 | | 2000 | 7 | 3 | 10 | | 2001 | 9 | 1 | 10 | | 2002 | 8 | 3 | 11 | | 2003 | 5 | 3 | 8 | | 2004 | 9 | 4 | 13 | | 2005 | 9 | 2 | 11 | | 2006 | 8 | 6 | 14 | | 2007 | 19 | 7 | 26 | | 2008 | 20 | 3 | 23 | | 2009 | 14 | 3 | 17 | | 2010 | 8 | 9 | 17 | | 2011 | 19 | 6 | 25 | | 2012 | 26 | 5 | 31 | | 2013 | 30 | 5 | 35 | | 2014 | 24 | 9 | 33 | | 2015 | 20 | 5 | 25 | | 2016 | 33 | 6 | 39 | | 2017 | 31 | 4 | 35 | | 2018 | 18 | 1 | 19 | | 2019 | 26 | 3 | 29 | | 2020 | 23 | 3 | 26 | | 2021 | 18 | 5 | 23 | | 2022 | 26 | 2 | 28 | | 2023 | 21 | 1 | 22 | | 2024 | 22 | 5 | 27 | | 2025 | 14 | 2 | 16 | | 2026 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
Stoop TF, Croce C, Ishida H, Ali M, Javed AA, Halimi A, Oba A, Groot Koerkamp B, Leonhardt CS, Thiels CA, Rangelova E, Sparrelid E, Sotirova I, Leiting JL, Tauchi J, Kobayashi K, Klos M, Beuk LPM, Genova L, Mastronardi M, Kendrick ML, Mughal NA, Busch OR, Franklin O, Larsson P, Klaiber U, Schulick RD, Theijse RT, Strobel O, Ghorbani P, de Wilde RF, Rodriguez Franco S, Sugawara T, Wilmink JW, Messersmith W, Besselink MG, Wolfgang CL, Inoue Y, Truty MJ, Del Chiaro M. Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study. BJS Open. 2026 May 12; 10(3).
-
Stoop TF, van 't Land FR, Seelen LWF, Ali M, Sultan A, Javed AA, van Eijck CHJ, Thiels CA, Hewitt DB, Sparrelid E, Uzunoglu FG, Gehrisch OHF, Daams F, Ishida H, van Santvoort HC, Molenaar IQ, Leiting JL, Erdmann JI, Cappelle M, Ginesini M, Kendrick ML, Napoli N, Busch OR, Franklin O, Ghorbani P, Schulick RD, Dankha R, de Wilde RF, Welsch T, Te Riele W, Wolfgang CL, Besselink MG, Groot Koerkamp B, Boggi U, Truty MJ, Del Chiaro M, Hackert T. Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection. BJS Open. 2026 May 12; 10(3).
-
Fountzilas C, Rosario S, Witkiewicz AK, Withers HG, Bajor DL, Mukherjee S, Saltzman J, Maguire O, Minderman H, Chatley S, Tarquini ML, Whitworth A, Jurcevic J, Hsiao HH, Knudsen ES, Muhitch JB, Abrams SI, Kalinski P, Segal BH, Bakin A, Yuan G, Wang C, Attwood K, Iyer R, Boland PM. TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab. Int J Cancer. 2026 Jun 15; 158(12):3300-3311.
-
Holmberg D, Liljequist Aspelund A, Wani S, Ness-Jensen E, Von Euler-Chelpin M, Kauppila JH, Santoni G, Lagergren J. Survival in post-endoscopy esophageal cancer: a Nordic population-based cohort study. Endoscopy. 2026 Jun; 58(6):588-594.
-
Enke T, Pokala SK, Hensen C, Brennan C, Gallegos J, Hochheimer CJ, Muthusamy VR, Thaker AM, Kushnir V, Early D, Rastogi A, Hammad H, Edmundowicz SA, Komanduri S, Wani S. Recurrent Barrett's esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up. Dis Esophagus. 2026 Jan 09; 39(1).
-
Boysen M, Lai SH, Byers S, Widmar M, Loria A, Russell T, Abelson JS, Fleming FJ, Monson JR, Vogel JD. Rectal Cancer Watch-and-Wait Management of Patients With Tumors Within Versus Beyond the Reach of Digital Rectal Examination. Ann Surg Oncol. 2026 Apr; 33(4):2856-2864.
-
Zhou MJ, Sawas T, Leiman DA, Wani S. Clinical Utility of Biomarkers for Barrett's Esophagus: Guidelines and Future Directions. Gastroenterol Clin North Am. 2026 Mar; 55(1):21-37.
-
Strong Caldwell A, Milner DC, Mehta NB, Marin AI, Gill ZS, Manoharan N. MERTK INHIBITOR-ASSOCIATED RETINAL TOXICITY IN A HUMAN. Retin Cases Brief Rep. 2025 Nov 01; 19(6):807-810.
-
Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P. AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus. Gastroenterology. 2025 Nov; 169(6):1184-1231.
-
Sawas T, Benson JT, Allen A, Wang K, Wani S, Iyer PG, Katzka DA. The metabolic profile of lean patients with esophageal adenocarcinoma and Barrett's esophagus. Dis Esophagus. 2025 Nov 01; 38(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|